Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood-brain barrier be a disease "sanctuary" during venetoclax treatment?

Richter's transformation blood‐brain barrier chronic lymphocytic leukemia leptomeningeal infiltration venetoclax

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 09 01 2021
accepted: 16 02 2021
entrez: 3 5 2021
pubmed: 4 5 2021
medline: 4 5 2021
Statut: epublish

Résumé

Our unique case of Richter's Transformation presenting as leptomeningial infiltration in a CLL patient receiving venetoclax raises questions on whether the drug penetrates the blood-brain barrier and at what extend, especially in reduced doses given for drug-drug interactions.

Identifiants

pubmed: 33936674
doi: 10.1002/ccr3.4002
pii: CCR34002
pmc: PMC8077271
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2249-2253

Informations de copyright

© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

None declared.

Références

Haematologica. 2019 May;104(5):e222-e223
pubmed: 30765472
Cancer. 2005 Jan 15;103(2):216-28
pubmed: 15578683
Am J Surg Pathol. 2007 Oct;31(10):1605-14
pubmed: 17895764
Blood. 2016 Nov 3;128(18):2199-2205
pubmed: 27601462
Leukemia. 2003 Dec;17(12):2257-317
pubmed: 14671650
Rev Med Interne. 1999 Jan;20(1):64-7
pubmed: 10220822
Am J Clin Pathol. 1988 Feb;89(2):254-9
pubmed: 3341285
J Clin Oncol. 1993 Oct;11(10):1985-9
pubmed: 8410123
JAMA Oncol. 2015 Apr;1(1):80-7
pubmed: 26182309
Br J Haematol. 2013 Sep;162(6):774-82
pubmed: 23841899
Blood. 2011 Mar 24;117(12):3391-401
pubmed: 21266718
Blood. 2017 Jun 22;129(25):3362-3370
pubmed: 28473407
Br J Haematol. 2008 Sep;142(5):709-16
pubmed: 18492119

Auteurs

Maria Dimou (M)

1st Propedeutic Internal Medicine Clinic Hematology Department and Molecular Laboratory in Hematology National and Kapodistrian University of Athens Athens Greece.

Aikaterini Bitsani (A)

1st Propedeutic Internal Medicine Clinic Hematology Department and Molecular Laboratory in Hematology National and Kapodistrian University of Athens Athens Greece.

Maria Roumelioti (M)

1st Propedeutic Internal Medicine Clinic Hematology Department and Molecular Laboratory in Hematology National and Kapodistrian University of Athens Athens Greece.

Aglaia Dimitrakopoulou (A)

1st Propedeutic Internal Medicine Clinic Hematology Department and Molecular Laboratory in Hematology National and Kapodistrian University of Athens Athens Greece.

Theodore Iliakis (T)

1st Propedeutic Internal Medicine Clinic Hematology Department and Molecular Laboratory in Hematology National and Kapodistrian University of Athens Athens Greece.

Vasileios Pardalis (V)

1st Propedeutic Internal Medicine Clinic Hematology Department and Molecular Laboratory in Hematology National and Kapodistrian University of Athens Athens Greece.

Ioannis Grafakos (I)

1st Propedeutic Internal Medicine Clinic Hematology Department and Molecular Laboratory in Hematology National and Kapodistrian University of Athens Athens Greece.

Sotiria Kalyva (S)

1st Propedeutic Internal Medicine Clinic Hematology Department and Molecular Laboratory in Hematology National and Kapodistrian University of Athens Athens Greece.

Athanasios Markopoulos (A)

1st Propedeutic Internal Medicine Clinic Hematology Department and Molecular Laboratory in Hematology National and Kapodistrian University of Athens Athens Greece.

Marie-Christine Kyrtsonis (MC)

1st Propedeutic Internal Medicine Clinic Hematology Department and Molecular Laboratory in Hematology National and Kapodistrian University of Athens Athens Greece.

Panayiotis Panayiotidis (P)

1st Propedeutic Internal Medicine Clinic Hematology Department and Molecular Laboratory in Hematology National and Kapodistrian University of Athens Athens Greece.

Classifications MeSH